Structural and Functional Characterization of the Enantiomers of the Antischistosomal Drug Oxamniquine.
Taylor, A.B., Pica-Mattoccia, L., Polcaro, C.M., Donati, E., Cao, X., Basso, A., Guidi, A., Rugel, A.R., Holloway, S.P., Anderson, T.J., Hart, P.J., Cioli, D., LoVerde, P.T.(2015) PLoS Negl Trop Dis 9: e0004132-e0004132
- PubMed: 26485649 
- DOI: https://doi.org/10.1371/journal.pntd.0004132
- Primary Citation of Related Structures:  
5BYJ, 5BYK - PubMed Abstract: 
For over two decades, a racemic mixture of oxamniquine (OXA) was administered to patients infected by Schistosoma mansoni, but whether one or both enantiomers exert antischistosomal activity was unknown. Recently, a ~30 kDa S. mansoni sulfotransferase (SmSULT) was identified as the target of OXA action.
Organizational Affiliation: 
Departments of Biochemistry, the University of Texas Health Science Center, San Antonio, Texas, United States of America; X-ray Crystallography Core Laboratory, the University of Texas Health Science Center, San Antonio, Texas, United States of America.